Home Videos Growth Stocks Lead; Eli Lilly Buys Loxo, Twilio Clears Resistance

Growth Stocks Lead; Eli Lilly Buys Loxo, Twilio Clears Resistance

by TradingETFs.com
Growth Stocks Lead; Eli Lilly Buys Loxo, Twilio Clears Resistance



Eli Lilly to buy Loxo Oncology for $8 billion or $235 a share. The iShares Nasdaq Biotech is surging today, and Twilio clears some resistance but doesn’t really …

source CNBC

Related Articles

Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy